These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 20732207)
1. Generation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro. van Pelt FN; Knight TL; Kenna JG Toxicol In Vitro; 1993 Jul; 7(4):311-5. PubMed ID: 20732207 [TBL] [Abstract][Full Text] [Related]
2. Formation of trifluoroacetylated protein antigens in cultured rat hepatocytes exposed to halothane in vitro. Van Pelt FN; Kenna JG Biochem Pharmacol; 1994 Aug; 48(3):461-71. PubMed ID: 8068033 [TBL] [Abstract][Full Text] [Related]
3. Human hepatocytes express trifluoroacetylated neoantigens after in vitro exposure to halothane. Ilyin GP; Rissel M; Malledant Y; Tanguy M; Guillouzo A Biochem Pharmacol; 1994 Aug; 48(3):561-7. PubMed ID: 8068043 [TBL] [Abstract][Full Text] [Related]
4. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides. Christen U; Bürgin M; Gut J Mol Pharmacol; 1991 Sep; 40(3):390-400. PubMed ID: 1716732 [TBL] [Abstract][Full Text] [Related]
5. Metabolic basis for a drug hypersensitivity: antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the trifluoroacetyl group derived from halothane. Kenna JG; Satoh H; Christ DD; Pohl LR J Pharmacol Exp Ther; 1988 Jun; 245(3):1103-9. PubMed ID: 3385639 [TBL] [Abstract][Full Text] [Related]
6. Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes. Amouzadeh HR; Pohl LR Hepatology; 1995 Sep; 22(3):936-43. PubMed ID: 7657302 [TBL] [Abstract][Full Text] [Related]
7. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. Satoh H; Fukuda Y; Anderson DK; Ferrans VJ; Gillette JR; Pohl LR J Pharmacol Exp Ther; 1985 Jun; 233(3):857-62. PubMed ID: 3891968 [TBL] [Abstract][Full Text] [Related]
8. Absence of anti-trifluoroacetate antibody after halothane anaesthesia in patients exhibiting no or mild liver damage. Sakaguchi Y; Inaba S; Irita K; Sakai H; Nawata H; Takahashi S Can J Anaesth; 1994 May; 41(5 Pt 1):398-403. PubMed ID: 8055607 [TBL] [Abstract][Full Text] [Related]
9. The topography of trifluoroacetylated protein antigens in liver microsomal fractions from halothane treated rats. Kenna JG; Martin JL; Pohl LR Biochem Pharmacol; 1992 Aug; 44(4):621-9. PubMed ID: 1510711 [TBL] [Abstract][Full Text] [Related]
10. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation. Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014 [TBL] [Abstract][Full Text] [Related]
11. Detection of autoantibodies directed against human hepatic endoplasmic reticulum in sera from patients with halothane-associated hepatitis. Kitteringham NR; Kenna JG; Park BK Br J Clin Pharmacol; 1995 Oct; 40(4):379-86. PubMed ID: 8554940 [TBL] [Abstract][Full Text] [Related]
12. Concordance between trifluoroacetic acid and hepatic protein trifluoroacetylation after disulfiram inhibition of halothane metabolism in rats. Spracklin DK; Emery ME; Thummel KE; Kharasch ED Acta Anaesthesiol Scand; 2003 Jul; 47(6):765-70. PubMed ID: 12803597 [TBL] [Abstract][Full Text] [Related]
13. Metabolic activation of halothane to neoantigens in C57Bl/10 mice: immunochemical studies. Heijink E; De Matteis F; Gibbs AH; Davies A; White IN Eur J Pharmacol; 1993 Jun; 248(1):15-25. PubMed ID: 8339751 [TBL] [Abstract][Full Text] [Related]
14. Screening for antibodies associated with halothane hepatitis. Hastings KL; Thomas C; Hubbard AK; Gandolfi AJ Br J Anaesth; 1991 Dec; 67(6):722-8. PubMed ID: 1768541 [TBL] [Abstract][Full Text] [Related]
15. Detection of antibodies to a halothane metabolite hapten in sera from patients with halothane-associated hepatitis. Bird GL; Williams R J Hepatol; 1989 Nov; 9(3):366-73. PubMed ID: 2607125 [TBL] [Abstract][Full Text] [Related]
16. Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pig. Hastings KL; Thomas C; Brown AP; Gandolfi AJ Immunopharmacol Immunotoxicol; 1995 Feb; 17(1):201-13. PubMed ID: 7759772 [TBL] [Abstract][Full Text] [Related]
17. UDP-glucose:glycoprotein glucosyltransferase associates with endoplasmic reticulum chaperones and its activity is decreased in vivo by the inhalation anesthetic halothane. Amouzadeh HR; Bourdi M; Martin JL; Martin BM; Pohl LR Chem Res Toxicol; 1997 Jan; 10(1):59-63. PubMed ID: 9074803 [TBL] [Abstract][Full Text] [Related]
18. Trifluoroacetylated adducts in spermatozoa, testes, liver and plasma and CYP2E1 induction in rats after subchronic inhalatory exposure to halothane. Oropeza-Hernández LF; Quintanilla-Vega B; Reyes-Mejía RA; Serrano CJ; García-Latorre EA; Dekant W; Manno M; Albores A Toxicol Lett; 2003 Sep; 144(1):105-16. PubMed ID: 12919728 [TBL] [Abstract][Full Text] [Related]
19. Localization of halothane-induced antigen in situ by specific anti-halothane metabolite antibodies. Hubbard AK; Roth TP; Schuman S; Gandolfi AJ Clin Exp Immunol; 1989 Jun; 76(3):422-7. PubMed ID: 2752596 [TBL] [Abstract][Full Text] [Related]
20. Halothane metabolism: Kupffer cells carry and partially process trifluoroacetylated protein adducts. Christen U; Bürgin M; Gut J Biochem Biophys Res Commun; 1991 Feb; 175(1):256-62. PubMed ID: 1998510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]